Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein? - PubMed (original) (raw)
Review
Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein?
R N Bergman. Diabetologia. 2000 Jul.
Abstract
Aims/hypothesis: Insulin control of glucose output is a major mechanism by which appropriate amounts of glucose are produced to supply energy to the central nervous system, without causing long-term increases of the plasma glucose concentration. It is hypothesised that the primary route by which insulin maintains control over glucose production is indirect and is mediated by regulation of non-esterified fatty acid release from the adipocyte. The question arises as to why evolution has chosen insulin to be secreted into the portal vein, if control of the liver is partially or primarily indirect. It is suggested that alterations in hepatic insulin clearance which attend increases in central adiposity are an important part of the compensation for insulin resistance and limit the necessity for up-regulation of insulin secretion in insulin resistance secondary to central adiposity.
Methods: Review of research from author's group and other laboratories.
Results: Data over the previous decade indicate that suppression of glucose output by increased insulin is a relatively slow process, much slower than the rate of binding of insulin to hepatocytes. One explanation is that insulin acts on an extrahepatic tissue, which in turn alters a signal to the liver, reducing glucose output. Additional evidence for an extrahepatic primary effect of insulin emerges from experiments in which insulin was given portally or peripherally at half the portal dose. Endogenous glucose production was related to systemic, not portal insulin, supporting the concept that the primary step in insulin's action on liver is on some other tissue, altering signalling to the liver itself. Strong correlation between plasma non-esterified fatty acids (NEFA) and liver glucose output suggests that the primary effect is on the adipocyte. The primacy of the adipocyte locus for the insulin effect included data that insulin's action on liver is prevented when plasma NEFA are maintained, as well as data showing proportional decline in glucose production and fatty acids when antilipolysis is induced by an adenosine agonist. Why then, from an evolutionary point of view is insulin secreted into the portal vein? Institution of central adiposity in dogs with fat feeding causes hepatic insulin resistance, at least partially due to the provision of NEFA in portal blood. The initial response to resistance is enhanced beta-cell sensitivity to glucose; a secondary compensation is, however, a substantial reduction in liver clearance, allowing for a greater proportion of secreted insulin to reach muscle, where it can more efficiently stimulate glucose utilisation.
Conclusion/interpretation: Non-esterified fatty acids act as a signal as well as a metabolic substrate. They can regulate glucose utilisation in muscle and apparently are important signals to the liver and the beta cells as well. The importance of portal vein NEFA concentrations to the function of the liver could explain insulin resistance of the liver with central pattern obesity.
Comment in
Similar articles
- Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin.
Rebrin K, Steil GM, Getty L, Bergman RN. Rebrin K, et al. Diabetes. 1995 Sep;44(9):1038-45. doi: 10.2337/diab.44.9.1038. Diabetes. 1995. PMID: 7657026 - New concepts in extracellular signaling for insulin action: the single gateway hypothesis.
Bergman RN. Bergman RN. Recent Prog Horm Res. 1997;52:359-85; discussion 385-7. Recent Prog Horm Res. 1997. PMID: 9238859 Review. - The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog.
Sindelar DK, Chu CA, Rohlie M, Neal DW, Swift LL, Cherrington AD. Sindelar DK, et al. Diabetes. 1997 Feb;46(2):187-96. doi: 10.2337/diab.46.2.187. Diabetes. 1997. PMID: 9000693 - Central role of the adipocyte in the metabolic syndrome.
Bergman RN, Van Citters GW, Mittelman SD, Dea MK, Hamilton-Wessler M, Kim SP, Ellmerer M. Bergman RN, et al. J Investig Med. 2001 Jan;49(1):119-26. doi: 10.2310/6650.2001.34108. J Investig Med. 2001. PMID: 11217141 Review.
Cited by
- Celiac artery mesenteric fat measurement with endosonography (CAMEUS) reliably correlates with obesity and related comorbidities.
Bazerbachi F, Baroud S, Levy MJ, Maselli DB, Vargas EJ, Bofill-Garcia A, Law RJ, Chandrasekhara V, Storm AC, Gleeson FC, Rajan E, Iyer PG, Watt KD, Abu Dayyeh BK. Bazerbachi F, et al. Gastroenterol Rep (Oxf). 2024 Apr 26;12:goae039. doi: 10.1093/gastro/goae039. eCollection 2024. Gastroenterol Rep (Oxf). 2024. PMID: 38681751 Free PMC article. - The Basis for Weekly Insulin Therapy: Evolving Evidence With Insulin Icodec and Insulin Efsitora Alfa.
Rosenstock J, Juneja R, Beals JM, Moyers JS, Ilag L, McCrimmon RJ. Rosenstock J, et al. Endocr Rev. 2024 May 7;45(3):379-413. doi: 10.1210/endrev/bnad037. Endocr Rev. 2024. PMID: 38224978 Free PMC article. Review. - Diabetes and diabesity in the view of proteomics, drug, and plant-derived remedies.
Haeri MR. Haeri MR. J Res Med Sci. 2023 Oct 26;28:77. doi: 10.4103/jrms.jrms_487_22. eCollection 2023. J Res Med Sci. 2023. PMID: 38152069 Free PMC article. Review. - Meta-Inflammation and De Novo Lipogenesis Markers Are Involved in Metabolic Associated Fatty Liver Disease Progression in BTBR ob/ob Mice.
Opazo-Ríos L, Soto-Catalán M, Lázaro I, Sala-Vila A, Jiménez-Castilla L, Orejudo M, Moreno JA, Egido J, Mas-Fontao S. Opazo-Ríos L, et al. Int J Mol Sci. 2022 Apr 2;23(7):3965. doi: 10.3390/ijms23073965. Int J Mol Sci. 2022. PMID: 35409324 Free PMC article. - A Combined Supplement of Probiotic Strains AP-32, bv-77, and CP-9 Increased Akkermansia mucinphila and Reduced Non-Esterified Fatty Acids and Energy Metabolism in HFD-Induced Obese Rats.
Liao CA, Huang CH, Ho HH, Chen JF, Kuo YW, Lin JH, Tsai SY, Tsai HY, Yeh YT. Liao CA, et al. Nutrients. 2022 Jan 26;14(3):527. doi: 10.3390/nu14030527. Nutrients. 2022. PMID: 35276886 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical